Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below:


	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
Equity plan expense (a)	$	32.7	$	29.1	$	97.7	$	163.8

Liability plan (income) expense	0.9		(0.6)		1.2		0.5
Fringe expense	—		0.3		1.5		2.5
Total share-based compensation expense	$	33.6	$	28.8	$	100.4	$	166.8

(a) Equity plan share-based compensation expense of $32.7 and $29.1 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended March 31, 2023 and 2022, respectively. Equity plan share-based compensation expense of $97.7 and $163.8 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the nine months ended March 31, 2023 and 2022, respectively.

As of March 31, 2023, the total unrecognized share-based compensation expense related to stock options, Series A Preferred Stock, restricted stock, and restricted stock units and other share awards is $1.2, $0.0, $3.9 and $103.8, respectively. The unrecognized share-based compensation expense related to stock options, Series A Preferred stock, restricted stock, and restricted stock units and other share awards is expected to be recognized over a weighted-average period of 1.11, 0.00, 2.07 and 1.43 years, respectively.

The Company granted nil and 8.3 million shares of RSUs and other share awards during the three and nine months ended March 31, 2023, respectively. The Company recognized share-based compensation expense of $32.1 and $29.4 for the three months ended March 31, 2023 and 2022, respectively, of which $23.0 and $22.6 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $97.3 and $166.6 for the nine months ended March 31, 2023 and 2022, respectively, of which $70.1 and $146.6, respectively, related to Ms. Nabi's award.

The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. The Award will vest and settle in 10.0 million shares of the Company’s Class A Common Stock, par value $0.01 per share, on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to her continued employment through each such date. The Company will recognize the share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested.

In connection with this Award, on October 29, 2021, JAB Beauty B.V., the Company’s largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., completed the transfer of 10.0 million shares of Class A Common Stock to Ms. Nabi. In the event Ms. Nabi remains employed through the third vesting date, JAB Beauty B.V. has agreed, pursuant to an equity transfer agreement, to transfer to Ms. Nabi (either directly or through contributing to the Company) an additional 5.0 million shares of Class A Common Stock to Ms. Nabi.

On August 31, 2022, the Company issued 10.0 million shares of Class A Common Stock to Ms. Nabi in connection with the second vesting of the Award.

The Company granted 0.0 million and 0.4 million shares of restricted stock, during the three and nine months ended March 31, 2023, respectively. The Company recognized share-based compensation expense of $0.7 and $0.7 for the three months ended March 31, 2023 and 2022, respectively, and $1.9 and $1.2 for the nine months ended March 31, 2023 and 2022, respectively.

The Company granted no shares of Series A Preferred Stock or Series A-1 Preferred Stock during the three and nine months ended March 31, 2023, respectively. The Company recognized share-based compensation expense (income) of $0.6 and $(0.7) for the three months ended March 31, 2023 and 2022, respectively, and $0.4 and $0.2 for the nine months ended March 31, 2023 and 2022, respectively.

The Company granted no non-qualified stock options during the three and nine months ended March 31, 2023. The Company recognized share-based compensation expense (income) of $0.2 and $(0.6) for the three months ended March 31, 2023 and 2022, respectively, and $0.8 and $(1.2) for the nine months ended March 31, 2023 and 2022, respectively.